Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Zhengbin Yao Insider Profile
4 Followers
Zhengbin Yao, CEO, Director at Viela Bio, holds 0.00 shares in Viela Bio (Ticker: VIE), holds ― shares in NexImmune (Ticker: NEXI), holds 23.53K shares in Alumis Inc. (Ticker: ALMS).
Zhengbin Yao Viela Bio (VIE)CEO, Director
Viela Bio (VIE)
CEO, Director
Not Ranked
Zhengbin Yao has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Zhengbin Yao
Zhengbin Yao's Trading History
Viela Bio
Mar 15, 2021
―
Uninformative Sell
24.92M
$0.00
NexImmune
―
Director
―
―
Alumis Inc.
Jul 01, 2024
Director
Uninformative Buy
―
$207.53K
List of latest transactions for each holding click on a transaction to see Zhengbin Yao's performance on stock
You May Also Like
Zhengbin Yao insider profile FAQ
What is the percentage of profitable transactions made by Zhengbin Yao?
The percentage of profitable transactions made by Zhengbin Yao is ―.
What is the average return per transaction made by Zhengbin Yao?
The average return per transaction made by Zhengbin Yao is ―.
What stocks does Zhengbin Yao hold?
Zhengbin Yao holds: VIE, NEXI, ALMS stocks.
What was Zhengbin Yao’s latest transaction?
Zhengbin Yao latest transaction was an Uninformative Sell of $24.92M.
What was Zhengbin Yao's most profitable transaction?
Zhengbin Yao’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Zhengbin Yao's role in Viela Bio?
Zhengbin Yao's role in Viela Bio is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.